ConductScience.org, home

Paper38332012

Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function.

Tian C and 19 others. Nat Commun, 2024. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function. Papers, record 38332012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38332012

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function.
PubMed
Journal
Nat Commun
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.67, provisional
iCite
Revised in PubMed
2026-06-04
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tian CChenxihttps://orcid.org/0000-0001-8103-789X
2Wang YYu
3Su MMiya
4Huang YYuanyuan
5Zhang YYuwei
6Dou JJiaxiang
7Zhao CChangfeng
8Cai YYuting
9Pan JJun
10Bai SShiyu
11Wu QQielan
12Chen SSanwei
13Li SShuhang
14Xie DDi
15Lv RRong
16Chen YYusheng
17Wang YYucaihttps://orcid.org/0000-0001-6046-2934
18Fu SSichenghttps://orcid.org/0000-0001-8926-8123
19Zhang HHuiminhttps://orcid.org/0000-0003-0895-5920
20Bai LLihttps://orcid.org/0000-0002-9028-1920

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Natural Killer T-CellsMajor topic
NeoplasmsMajor topic
Humans
Lymphocyte Activation
Immunotherapy
Macrophages
Antigens, CD1d

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
32325020National Natural Science Foundation of China (National Science Foundation of China)PubMed
92254304National Natural Science Foundation of China (National Science Foundation of China)PubMed
82202022National Natural Science Foundation of China (National Science Foundation of China)PubMed
82101912National Natural Science Foundation of China (National Science Foundation of China)PubMed
82372778National Natural Science Foundation of China (National Science Foundation of China)PubMed
82071736National Natural Science Foundation of China (National Science Foundation of China)PubMed
82371732National Natural Science Foundation of China (National Science Foundation of China)PubMed

Source PubMed

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123171661Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.Brain2012https://conductscience.org/library/papers/23171661PubMed
223761735BMP signaling in telencephalic neural cell specification and maturation.Front Cell Neurosci2013https://conductscience.org/library/papers/23761735PubMed
326042123Intravital imaging - dynamic insights into natural killer T cell biology.Front Immunol2015https://conductscience.org/library/papers/26042123PubMed
428419443Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice.Immunology2017https://conductscience.org/library/papers/28419443PubMed
519411762Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.J Clin Invest2009https://conductscience.org/library/papers/19411762PubMed
636208623The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes.Cell2022https://conductscience.org/library/papers/36208623PubMed
730258446ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes.Front Immunol2018https://conductscience.org/library/papers/30258446PubMed
835944541Melanopsin retinal ganglion cells mediate light-promoted brain development.Cell2022https://conductscience.org/library/papers/35944541PubMed
932516575Distinct iNKT Cell Populations Use IFNγ or ER Stress-Induced IL-10 to Control Adipose Tissue Homeostasis.Cell Metab2020https://conductscience.org/library/papers/32516575PubMed
1034343496CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.Cell2021https://conductscience.org/library/papers/34343496PubMed
1134106045Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021https://conductscience.org/library/papers/34106045PubMed
1231467405Dendritic cells in cancer immunology and immunotherapy.Nat Rev Immunol2020https://conductscience.org/library/papers/31467405PubMed
1317259969Regulation of T-cell activation by the cytoskeleton.Nat Rev Immunol2007https://conductscience.org/library/papers/17259969PubMed
1435552271LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.J Clin Invest2022https://conductscience.org/library/papers/35552271PubMed
1529614819Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.Int J Mol Sci2018https://conductscience.org/library/papers/29614819PubMed
1635210567VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells.Nat Cell Biol2022https://conductscience.org/library/papers/35210567PubMed
1733362769T Cell Motility─How Is It Regulated?Front Immunol2020https://conductscience.org/library/papers/33362769PubMed
1817308126Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.Cancer Res2007https://conductscience.org/library/papers/17308126PubMed
1930171164LFA-1 Ligation by High-Density ICAM-1 Is Sufficient To Activate IFN-γ Release by Innate T Lymphocytes.J Immunol2018https://conductscience.org/library/papers/30171164PubMed
2029634943T Cell Dysfunction in Cancer.Cancer Cell2018https://conductscience.org/library/papers/29634943PubMed

See all 67 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
41755879Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design.JACS Au2026https://conductscience.org/library/papers/41755879PubMed
41493506Redefining cell therapy: CAR-engineered innate immune cells to conquer solid and hematologic malignancies.Mol Biol Rep2026https://conductscience.org/library/papers/41493506PubMed
40995371Visualizing cellular interactions: intravital imaging in tumor microenvironment.Front Immunol2025https://conductscience.org/library/papers/40995371PubMed
40963926The first abdominal aortic aneurysm organoid model replicates complex microenvironment for in vitro disease study.Theranostics2025https://conductscience.org/library/papers/40963926PubMed
40718496CAR-iNKT cells: redefining the frontiers of cellular immunotherapy.Front Immunol2025https://conductscience.org/library/papers/40718496PubMed
40698085Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis.Front Immunol2025https://conductscience.org/library/papers/40698085PubMed
40583406NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy.Immunotherapy2025https://conductscience.org/library/papers/40583406PubMed
40514544Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design.Nat Rev Immunol2025https://conductscience.org/library/papers/40514544PubMed
40165901Inflammation and cancer: molecular mechanisms and clinical consequences.Front Oncol2025https://conductscience.org/library/papers/40165901PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD1D912PubTator's text mininghttps://conductscience.org/library/genes/912NCBI Gene
CDC42998PubTator's text mininghttps://conductscience.org/library/genes/998NCBI Gene
ITGA43676PubTator's text mininghttps://conductscience.org/library/genes/3676NCBI Gene
VCAM17412PubTator's text mininghttps://conductscience.org/library/genes/7412NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
SRAPRJNA946041

Source SRA

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38332012

GET https://conductscience.org/api/papers/v1/38332012/references?page=2